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Hoarseness and sore throat are common layryngopharyngeal complications 
following endotracheal intubation. Thermosoftening method and intravenous 
administration of dexamethasone are known to be effective reducing the 
laryngopharyngeal complications. We combined two methods of 
thermosoftening of DLT and prophylactic dexamethasone administration 
0.1mg/kg to minimize the larynopharyngeal injury during DLT intubation. 
 
Methods 
Patients (n=157) undergoing thoracic surgery using DLT were randomized 
into three groups. Group TD (thermosoftening + dexamethasone), whose DLT 
was thermosoftened with 40℃ normal saline bottle and received intravenous 
administration of dexamethasone 0.1mg/kg; Group D (no thermosoftening + 
ii 
 
dexamethasone) whose DLT was not thermosoftened and received intravenous 
administration of dexamethasone 0.1 mg/kg; Group C (no thermosoftening + 
0.9% saline) whose DLT was not thermosoftened and received a placebo of 




The incidence of hoarseness at had significant differences among the three 
groups (P=0.028). Group TD showed lower incidence of hoarseness at 24 
hour compared with Group C (17% vs 42%, P=0.008). The incidence of sore 
throat was comparable between the three groups. 
 
Conclusions 
Combined treatment of thermosoftening and intravenous administration of 
dexamethasone 0.1 mg/kg can reduce the postoperative hoarseness at 24 hour 
following one lung anesthesia using double lumen tube. 
------------------------------------------------- 
Keywords : Intubation, Airway management, Anesthesia, General, 
Dexamethasone, Hoarseness 
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Hoarseness and sore throat are common laryngopharyngeal complications 
following endotracheal intubation.
1, 2
 Double lumen tube (DLT) used for lung 
isolation is known to produce more laryngopharyngeal morbidities than single 
lumen tube does. 
3, 4
 DLTs increase the potential to increase the risk of 
laryngopharyngeal injury due to a larger external diameter, elliptical shape on cross-




Dexamethasone is a widely used potent glucocorticoid with analgesic, anti-
inflammatory properties. Single dose of intravenous dexamethasone has been used 
to reduce the incidence and severity of laryngopharyngeal complications with 
minimal side effects. Though its impact on hoarseness and sore throat remains 
unclear since the results from different studies used a variety of intravenous 
dexamethasone dose
6-10






 reported that thermosoftening of nasotracheal tube with warm saline 
can reduce the complication of epistaxis or nasal damage. Because the DLT is made 
of polyvinyl chloride like nasotracheal tube, we can expect that thermosoftening of 
DLT will alleviate the laryngopharyngeal damage during endotracheal intubation 
(IRB H-1204-030-404, not yet published). 
Therefore, we set a 3-group study adding thermosoftening method to intravenous 
administration of dexamethasone 0.1mg/kg. The purpose of this study was to 
determine combined treatment of thermosoftening and intravenous administration 
of dexamethasone can reduce the laryngopharyngeal complications following one 





The study protocol was approved by Seoul National University Hospital 
Institutional Review Board (Ref. H-1311-088-536). After obtaining written 
informed consents, patients who were scheduled for elective thoracic surgery 
requiring the placement of a left-sided DLT and aged from 20 to 75 were enrolled in 
the study from May to October 2014. Any patients with a preexisting hoarseness or 
sore throat, laryngeal or upper airway disease, symptom of hoarseness or sore throat, 
allergy to dexamethasone, recent use of corticosteroid, active infection state, recent 
history of live vaccination were excluded from the study. We also excluded the 
patients suspected to have difficulties with airway management such as Mallampati 
score of 3 or 4, long anesthesia time over 6 hours. The patients were randomly 
assigned to one of the three groups using a computer generated randomization list. 
 
Clinical Procedures 
Before the induction of anesthesia, patients were randomly assigned to one of three 
groups: Group TD (thermosoftening + dexamethasone), whose DLT was 
thermosoftened at 40℃ normal saline and received dexamethasone 0.1mg/kg; 
Group D (dexamethasone + 0.9% saline) whose DLT was not thermosoftened and 
received dexamethasone 0.1 mg/kg; Group C (placebo + 0.9% saline) whose DLT 
was not thermosoftened and received a placebo of 0.9% saline. 
The anesthesiology resident not participating in postoperative patient evaluation 
prepared the study drugs as a 3ml clear solution in identical syringes. The 
randomization group and the identity of the study drugs were all blinded from the 
patients, intubating or participating anesthesiologist during surgery, and the 
investigator who collected the postoperative data. In group C and group D, DLT was 
3 
 
prepared in a 1L saline bottle stored at room temperature. In group TD, DLT was 
prepared in a 1L saline bottle warmed to 40°C. Because warmed saline bottle’s 
upper inner surface was vaporized and could be differentiated with cold saline bottle 
by eyes, external surface was wrapped with a cotton blanket and intubating 
anesthesiologist could not determine whether the DLT was warmed or not. 
The DLT size was selected according to the gender and the height of patients.
13
 We 
used a 39 Fr DLT for men taller than 178 cm; a 37 Fr DLT for men 160–178 cm tall 
and for women taller than 165 cm; a 35 Fr DLT for men shorter than 160 cm and for 
women 153–165 cm tall; and a 32 Fr DLT for women shorter than 153 cm. 
Patient received no premedication and standard monitoring was established. 
General anesthesia was induced with total intravenous anesthesia with propofol 
(Fresofol MCT 2% Inj., Fresenius Kabi, Graz, Austria) and remifentanil (Ultiva® , 
GlaxoSmithKline, Parma, Italy) at 5 µg/ml and 5 ng/ml, respectively. After 
confirming the patient’s loss of consciousness, rocuronium 0.8mg/kg with study 
drug (dexamethasone or 0.9% saline for each group) was injected. Tracheal 
intubation was performed with a disposable polyvinyl chloride left-sided DLT 
(Broncho-Cath® , Mallinckrodt Medical Ltd., Athlone, Ireland) by an experienced 
anesthesiologist. The DLTs were initially inserted into the glottis with the bronchial 
tip directing anterior under direct laryngoscopy using either a Macintosh 3 or 4 
laryngoscope blade. After the bronchial tip passed the vocal cords, the stylet was 
removed and the DLT was rotated 90° counterclockwise and advanced until slight 
resistance was met. The DLT position was adjusted under direct vision of a 
fiberoptic bronchoscope (LF-DP or LF-GP, Olympus Optical Co., Tokyo, Japan) 
after removal of the headrest used during intubation.
14
 After completing positional 
change, the DLT position was reassessed by fiberoptic bronchoscope. Subsequent 
anesthetic management was performed by the anesthesiologist who was unaware of 
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the group assignment and not involved in the study. Anesthesia was maintained with 
propofol and remifentanil and rocuronium was administered at intervals of 30–40 
min to maintain neuromuscular block, but it was not given within 1 h of the end of 
surgery. Immediately after completion of surgery, the patient was repositioned to 
supine and pyridostigmine 0.3 mg/kg with glycopyrrolate 0.01 mg/kg were 
administered to reverse neuromuscular block. After gentle suctioning of oral 
secretions and the DLT was carefully extubated. 
Intravenous patient controlled analgesia (IVPCA) or patient controlled epidural 
analgesia (PCEA) was used to manage postoperative pain. The IVPCA consisted of 
fentanyl 10~20 mcg/ml and morphine 0.4~0.7 mg/ml with total volume 100 ml at a 
continuous infusion rate of 0.5 ml/h and a bolus 1 ml with a lockout interval 10 min. 
The PCEA consisted of 0.12 % levobupivacaine and fentanyl 2 mcg/ml with total 
volume 500 ml at a continuous infusion rate of 6 ml/h and a bolus 0.5ml with a 




During direct laryngoscopy, Cormack and Lehane’s grading
15
 was used to assess 
the glottis exposure. The resistance during an advance of DLTs through the glottis 
was subjectively evaluated as none, mild, moderate, or severe by the intubating 
anesthesiologist. Severe resistance was defined as the inability to advance DLTs 
without rotating 180° counterclockwise to direct the tracheal lumen anteriorly and 
then advanced until the tip of the tracheal lumen passed beyond the vocal cords.
5
 
 The severity of postoperative sore throat and hoarseness was the primary outcome 
of this study. A blinded investigator visited and assessed patients for sore throat and 
hoarseness in the recovery and first, second, third postoperative day. Sore throat was 
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defined as a continuous throat pain and hoarseness was defined an acoustic quality 
that was different from the preoperative voice quality of the patient. The examiner 
recorded the occurrence of sore throat and hoarseness or not. 
 
Statistical analysis 
In previous studies by Knoll et al.
3
, 44% of patients complained of sore throat 24 
hour after DLT intubation. We considered a 50% reduction in the incidence of sore 
throat to be clinically significant. Assuming a Type-I error protection of 0.05 and a 
power of 0.80, 46 patients were needed in each group. Considering the drop rate of 
10%, we needed 156 patients to enroll. Data were expressed using mean (±standard 
deviation) for continuous variables as proportions for categorical data. Chi-square 
test or Fisher’s exact test was used to analyze the difference in sex, DLT size, 
laryngoscopic grade, resistance during DLT advance, surgical side, the incidence of 
sore throat. Analysis of variance (ANOVA) test was used to analyze the difference 
in height, body weight, surgical time, anesthesia time with bonferroni correction for 
the post hoc analysis. For our primary endpoint (sore throat and hoarseness at 
operation day with the first and second postoperative day) we used a 2×3 chi-square 
test to compare three groups. SPSS software (version 18.0; SPSS, Inc., Chicago, IL, 
USA) was used for the statistical analysis. All reported P-values were two-sided and 





After screening 278 patients (Fig. 1), seventy-six patients did not meet the 
inclusion criteria and 45 patients refused to participate. A total of 157 patients were 
randomized and 18 patients were excluded from analysis. One hundred and thirty-
nine patients were finally analyzed; 47 patients were allocated to the group C and 
46 patients were allocated to the group D and the group TD, respectively. 
Demographic data for the 149 patients are shown in Table 1. There were no 
differences among the three groups with respect to age, height, weight, sex. 
Variables associated with tracheal intubation are listed in Table 2. Cormack and 
Lehane scores, DLT size, resistance, intubation time, type of surgery, surgical side 
and duration of anesthesia did not differ among the three study groups. 
An incidence of postoperative laryngopharyngeal discomfort is listed in Table 3. 
The symptom of sore throat was maximal at 2 hour (Group C 26% and Group D 
33%) or 24 hour (Group TD 28%). The incidence of sore throat at 2 hour, 24 hour, 
48 hour after extubation showed no difference among three groups. 
The symptom of hoarseness was maximal at 2 hour (Group D 37%) or 24 hour 
(Group D 42% and Group TD 24%). The incidence of postoperative hoarseness at 
24 hour (Figure 2) had significant differences among the three groups (P=0.028). 
Group TD showed lower incidence of hoarseness at 24 hour compared with Group 
C (17% vs 42%, P=0.008) but showed little difference compared with Group D (17% 
vs 28%, P=0.214). Group D had little difference compared with Group C (28% vs 
42%, P=0.150). The incidence of postoperative hoarseness at 2 hour and 48 hour 
showed no significant difference. No patient showed complications associated with 























Age(yr) 59.6±12.6 53.9±15.7 56.8±13.2 56.8±14.0 0.144 
Height(cm) 162.0±10.5 164.3±10.4 163.5±9.2 163.3±10.0 0.511 
Weight(kg) 65.0±31.1 66.4±31.9 60.4±19.2 64.0±26.2 0.525 
Sex(male/female) 20/27 25/21 28/18 73/66 0.200 
Type of Surgery 
(VATS/thoracotomy) 
41/6 44/2 40/6 125/14 0.311 * 
Surgical side 
 (left/right/both) 
20/25/2 14/32/0 14/25/4 48/85/6 0.177 
 
Values are expressed as the mean ± SD or number of patients. 
Group C, control group (no thermosoftening + 0.9% saline); Group D, dexamethasone group (no 
thermosoftening + dexamethasone); Group TD, combined treatment group (thermosoftening + 
dexamethasone) 
VATS, video-assisted thoracoscopic surgery. 













All patients p value 
Laryngoscope grade 
(Cormack I / II) 
34/13 29/17 35/11 98/41 0.343 * 
DLT size(32/35/37/39) 3/25/11/8 6/17/14/9 2/19/19/6 11/61/44/23 0.331 
Resistance(0/1/2/3) 6/22/17/2 6/27/10/3 15/21/9/1 27/70/36/6 0.100 * 
Time to achieve 
 intubation (sec) 
28.3±12.3 26.3±10.1 26.2±11.3 27.0±11.3 0.617 
Duration of 
anesthesia(min) 
209.4±65.5 190.6±56.8 205.9±72.1 202.0±65.1 0.340 
 
Values are expressed as the number of patients or mean ± SD. 
Group C, control group (no thermosoftening + 0.9% saline); Group D, dexamethasone group (no 
thermosoftening + dexamethasone); Group TD, combined treatment group (thermosoftening + 
dexamethasone) 
DLT, double-lumen endobronchial tube 













p value for 
Group D vs 
Group C 
p value for 
Group TD 
vs Group D 
p value for 
Group TD 
vs Group C 
Overall 
p value 
2 h after extubation        
Sore throat 12(26%) 15(33%) 12(26%) 0.452 0.492 0.951 0.702 
Hoarseness 16(34%) 17(37%) 11(24%) 0.769 0.174 0.282 0.369 
24h after extubation        
Sore throat 11(23%) 13(28%) 13(28%) 0.593 1.000 0.593 0.829 
Hoarseness 20(42%) 13(28%) 8(17%) 0.150 0.214 0.008 0.028 
48h after extubation        
Sore throat 9(19%) 7(15%) 9(20%) 0.615 0.582 0.959 0.835 
Hoarseness 16(33%) 11(24%) 8(17%) 0.282 0.613 0.115 0.262 
 
Data are number of patients (%). 
Group C, control group (no thermosoftening + 0.9% saline); Group D, dexamethasone group (no thermosoftening + dexamethasone); Group TD, combined 




Figure 2. Hoarseness at 24 hours after extubation 
 
 






There had been no published investigation that evaluated the role of combined 
treatment of dexamethasone administration and thermosoftening of DLT to reduce 
the incidence and severity of laryngopharyngeal complications like hoarseness and 
sore throat after short-term intubation period. The results of this study showed that 
combined treatment of 0.1 mg/kg of dexamethasone given before tracheal 
intubation and thermosoftening of a DLT decreased the incidence of postoperative 
hoarseness 24 hour after endotracheal extubation of the DLT compared with placebo 
group. 
In a previous study
8
, 0.1 mg/kg dexamethasone was effective for reducing the sore 
throat and hoarseness 1 hour after DLT extubation compared with placebo group. In 
our study, 0.1 mg/kg dexamethasone monotreatment had a tendency to reduce 
hoarseness compared with placebo group at 24 hour (42% vs 28%, P=0.150) and 48 
hour (33% vs 24%, p=0.282) but statistically not significant. The difference of two 
study results may have originated from the difference of intubation and 
manipulation technique of DLT, clinical procedural settings or proceduring 
anesthesiologist. 
There is a large variation in the reported incidence (24~57%) of sore throat 
immediately after short term DLT intubation.
3, 5, 8, 16, 17
 In our current study, the 
overall incidence of posteoperative sore throat was 26% in the group C (placebo). 
The reasons for the low incidence of postoperative sore throat in our study may be 
difference of induction protocol, intubation technique and a use of postoperative 
IVPCA, PCEA or additional analgesics, marginal effective dose of intravenous 
dexamethasone, but the practical reason for the different result from the previous 
studies could not be identified. 
13 
 
Thermosoftening of nasotracheal tube with warm saline can reduce the 
complication of epistaxis or nasal damage.
12
 Thermosoftening is a simple method to 
apply in the clinical practice with no potential complication. Because the DLT is 
made of polyvinyl chloride like nasotracheal tube, we expect that the thermosoftend 
DLT will reduce direct physical damage to the vocal cords during endotracheal 
intubation. Considering the result that combined treatment of thermosoftening and 
dexamethasone 0.1 mg/kg decreases the hoarseness following DLT intubation 
compared with placebo group, thermosoftening may have benefit in reducing the 
damage during the intubation of DLT. Because the damage to the vocal cord can be 
a large contributing factor to the laryngopharyngeal complications like sore throat 
and hoarseness
5
, softening of DLT by thermosoftening and anti-inflammatory effect 
of dexamethasone may act synergistically to minimize the vocal cord damage and 
following inflammatory reaction like edema. 
In a previous single lumen tube study
18
, the incidence and severity of postoperative 
sore throat and hoarseness after endotracheal intubation was reduced by the use of 
small tubes. The use of a DLT has been considered as a major risk factor for a 
higher frequency of postoperative hoarseness and sore throat compared with a 
single lumen tube due to its large outer diameter (13–14 mm for 37 French and 12–
13 mm for 35 French DLTs versus 10 mm for ID 7.5mm and 9.3 mm for ID 7.0 mm 
of single lumen tubes). Additional investigated risk factors of the postoperative sore 
throat and hoarseness are sex
19, 20
, duration or type of surgery
21, 22





. Risk factors known to contribute to vocal cord injuries 
were controlled in the current study. Additionally we excluded 6 patients with a 
laryngoscopic view grade 3 or more according to the Cormack and Lehane to avoid 
difficult airway interfere the results. 
14 
 
The word ‘sore throat’ is a simple description for broad spectrum of signs and 
symptoms. It seems to originate from oral mucositis, pharyngitis, laryngitis, 
tracheitis or dysphagia as a result of mucosal injury with resulting inflammation 
caused by the procedure of laryngoscopy, suctioning or irritating foreign object 
(endotracheal tube, LMA or oral airway).
24
 Though sore throat is a frequently 
complained complications from multiple causes following general anesthesia, it has 
subjective portion in its nature. On the other hand, hoarseness is a more direct 
evidence of damage confined to larynx.
25
 Furthermore, hoarseness can be evaluated 
obviously by an observer and pathologic changes in the larynx can be assessed via 
an endoscopy if needed. Considering the difference of characteristics between sore 
throat and hoarseness, it appears that hoarseness can be a more reliable marker than 
sore throat in evaluating the postoperative laryngopharyngeal injury following 
general anesthesia. 
A total of three anesthesiologists participated in the process of intubation. About 
the half of intubation of performed by Chung YS (n=73, 52.5%) and Seo JH 
performed 46 intubations (33.1%) and Cho CW performed 20 intubations (14.4%). 
Although statistical analysis showed no difference on the primary outcome of 
hoarseness and sore throat between three anesthesiologists, these operator’s 
different intubation skill or subtle technical tendency could influence the outcome. 
Dexamethasone is a steroidal agent used for decades and its pharmacological 
characteristics are relatively well known. The potential side effects of 
dexamethasone are hyperglycemia, peptic ulcer, susceptibility to infection, 
electrolyte imbalance. But those side effects are observed only in a long term use of 
high dose dexamethasone. We used minimal dose of dexamethasone (0.1mg/kg) to 
minimize the potential side effects. Although our study’s follow-up was only for 48 
hour and we did not have large enough patient sample size, we could not observe 
15 
 
any complications associated with a single use of dexamethasone (0.1 mg/kg) in this 
study. 
The study has several limitations. First, the primary endpoints were patient’s 
reports of subjective hoarseness and sore throat. Secondly, our results had partially 
negative or statistically insignificant results of primary endpoint, we cannot exclude 
that the sample too small to discriminate the difference. Third, the use of analgesics 
may affect the incidence of sore throat because we did not compare the total dose of 





In conclusion, combined treatment of thermosoftening and intravenous 
administration of dexamethasone 0.1 mg/kg can reduce the postoperative 
hoarseness at 24 hour following one lune anesthesia using double lumen tube. We 
recommend that anesthesiologist might consider using combined method of 
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 목쉼과 인후통은 기관내 삽관을 시행할 때 생기는 바람직하지 않은 인
후두 합병증들이다. 기관내 삽관 튜브를 thermosoftening시키는 방법과 정
맥내 dexamethasone을 투여하는 방법은 각각 인후두 합병증을 줄이는 데 
효과가 있는 것으로 알려져 있다. 저자들은 이중관 튜브의 기관내 삽관시 
생기는 후두 손상을 줄이기 위하여 이중관 튜브를 Thermosoftening시키는 




 흉부 수술을 받는 DLT를 사용하는 157명의 환자를 대상으로 하여 세 
그룹을 설정하였다. Group TD는40℃의 생리식염수에 DLT를 담궈놓아 
thermosoftening을 하면서 intubation 전에 0.1 mg/kg의 dexamethasone을 투
여하였으며, Group D는 상온의 생리식염수에 DLT를 담궈놓고 intubation 
전에 0.1 mg/kg의 dexamethasone을 투여하였고 Group C는 상온의 생리식염
수에 DLT를 담궈놓고 intubation 전에 생리식염수를 투여하였다. 수술후 2
째날까지의 목쉼과 인후통을 평가하였다. 
 
결과 
발관 후 24시간째에 평가하였을 때 세 그룹간의 목쉼 증상은 유의한 차
이를 보였다 (P=0.028). Group TD는 Group C에 비하여 낮은 목쉼 증상 발
생률을 보였다 (17% vs 42%, P=0.008). 세 그룹간에 인후통의 발생은 유의
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한 차이를 보이지 않았다. 
 
결론 
Thermosoftening과 dexamethasone 0.1 mg/kg정주법의 병용은 이중관 튜브를 
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